Journal
ACS APPLIED MATERIALS & INTERFACES
Volume 12, Issue 20, Pages 22433-22443Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsami.0c00871
Keywords
nitric oxide; diazeniumdiolates; primary amine; orthopedic implants; biofilm inhibition
Funding
- Engineering and Physical Sciences Institute [EP/M027325/1, EP/P023223/1]
- China Scholarship Council
- BBSRC [BB/R012415/1] Funding Source: UKRI
- EPSRC [EP/M027325/1, EP/P023223/1, EP/N51004X/1] Funding Source: UKRI
Ask authors/readers for more resources
Titanium implants in orthopedic applications can fail due to infection and impaired integration into the host. Most research efforts that facilitate osseointegration of the implant have not considered infection, and vice versa. Moreover, most infection control measures involve the use of conventional antibiotics which contributes to the global epidemic of antimicrobial resistance. Nitric oxide (NO) is a promising alternative to antibiotics, and while researchers have investigated NO releasing coatings, there are few reports on the function/robustness or the mechanism of NO release. Our comprehensive mechanistic study has allowed us to design, characterize, and optimize NO releasing coatings to achieve maximum antimicrobial efficacy toward bacteria with minimum cytotoxicity to human primary osteoblasts in vitro. As the antibiotic era is coming to an end and the future of infection control continues to demand new alternatives, the coatings described herein represent a promising therapeutic strategy for use in orthopedic surgeries.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available